Company / Depreciation & Amortization
Protara Therapeutics, Inc. Depreciation & Amortization History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$30.0K
FY2016
5-year range
$27.0K / $57.0K
FY2014-FY2016
Trend
+11.1%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $57,000 to $30,000 over the past 2 years.
Based on SEC 10-K filings.
$30,000 in FY2016.
Improved from $57,000 to $30,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, depreciation & amortization increased 11.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $30.0K | +11.1% |
| FY2015 | $27.0K | -52.6% |
| FY2014 | $57.0K | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026